Chris Metinko / Crunchbase News:
Genesis Therapeutics, which uses AI to discover and develop new medicines, raised a $200M Series B co-led by a16z, bringing its total funding to $280M — Artificial intelligence and biotech are two of the sectors that have been able to buck the current sluggish pace of venture capital spending.
Source link
